Unknown
Arbor Pharmaceuticals explores $1 bln-plus sale – sources
NEW YORK, Oct 2 (Reuters) – Arbor Pharmaceuticals LLC is exploring a sale that could fetch more than $1 billion for the privately-held specialty drugmaker, according to people familiar with the…
WellPoint boosts share buyback program by $5 bln
Oct 2 (Reuters) – U.S. health insurer WellPoint Inc increased its share repurchase authorization by $5 billion, taking the total program to $6 billion, the company said in a regulatory filing.
RLPC-Styrolution relaunches loan refinancing
LONDON, Oct 2 (Reuters) – German plastics maker Styrolution is relaunching a loan of around 1.4 billion euros equivalent (1.77 billion US dollar) to refinance existing debt and finance an…
